by Brian Wang on (#56MRZ)
Eli Lilly a Phase 3 trial studying LY-CoV555 for the prevention of SARS-CoV-2 infection and COVID-19 in residents and staff at long-term care facilities in the U.S. (skilled nursing facilities,...
Link | https://www.nextbigfuture.com/ |
Feed | http://feeds.feedburner.com/blogspot/advancednano |
Updated | 2025-04-22 07:03 |